Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financ

08.11.2023 - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2023, and introduced ...

Related Keywords

Minnesota , United States , New York , Ireland , Eden Prairie , Gary Maharaj , Sundance Sirolimus , Surmodics Inc , Transcend , Nasdaq , Total Revenue , Recent Business , Endovascular Issues , Vitro Diagnostics , Quarter Fiscal , Medical Device , Call Today , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Months Ended September , Year Ended September , Stockholder Equity , Cash Equivalents , Three Months Ended September , Fiscal Year Ending September , Distribution Agreement , Surmodics Stock , Surmodics Chart , Urmodics Kurs , Urmodics Aktie ,